NCT01425450View on ClinicalTrials.gov

Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Healthy Volunteer Study
Interventions
DRUG

HF1020

Single doses at 0.5 mg capsules, 2.5 mg capsules, 10 mg capsules, and 25 mg capsules in each of cohorts 1, 2, 3 and 4 respectively.

DRUG

HF1020 placebo

Single dose: HF1020 placebo capsule

Trial Locations (1)

M23 9QZ

Medicines Evaluation Unit, Manchester

All Listed Sponsors
lead

Trident Pharmaceuticals Inc

INDUSTRY

NCT01425450 - Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers | Biotech Hunter | Biotech Hunter